NAT10 and neoplasm: To further evaluate the effects of NAT10 on melanoma tumor growth and DTIC sensitivity in vivo, we established a NAT10-KD or WT A375 cell-derived xenograft mouse model of melanoma in NOD/SCID mice and then treated it with DTIC or vehicle control every 3 days (Figure 2K).